MZL
Clinical trials for MZL explained in plain language.
Never miss a new study
Get alerted when new MZL trials appear
Sign up with your email to follow new studies for MZL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New weapon against tough cancers: first human test of BAFF-R CAR-T therapy begins
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called BAFF-R CAR-T, for people with B-cell lymphomas that have come back or not responded to other treatments. The main goals are to check if the treatment is safe and to find the best dose. Researchers will als…
Matched conditions: MZL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Real-World trial tests three drug combinations for rare lymphoma
Disease control Not yet recruitingThis study aims to compare how well three different treatment combinations work for people newly diagnosed with marginal zone B-cell lymphoma, a type of blood cancer. Researchers will follow 131 patients receiving either BR, R2, or OR2 treatment regimens to see which approach bes…
Matched conditions: MZL
Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC